Takekai International, a professional asset management firm that offers comprehensive investment management capabilities that span across all main segments of the global capital markets, continually enhancing its existing platforms and value-creation expertise through innovation and refinement of technologies, today announced that the firm has signed a representation and collaboration agreement with one of the biggest hedge fund managers in Asia. The contract signing establishes the implementation of several index tracking tools in a new and innovative manner.
Takekai International, an established leader in the Asia asset management community, is constantly focused on business expansion and diversification in order to respond with the best investment services and products to increasing client demand. The latest developments have broadened the firm’s spectrum of investment tools as it plans to allocate a continuous flow of capital in the Top Hedge Fund’s ETFs.
Mr. Yahiro Katsumi, Global Chief Investment Strategist with the Takekai International Investment Council, declared:” Out of their Index 400, comprised of 400 hedge funds across a wide range of strategies, we are interested in tracking and investing in 30 of the Top Hedge Fund’s products. Therefore, as the minimum investment amount is $4.3 million in order to access the platform and we have a considerably higher commitment in mind in terms of capital, we have decided to sign a partnership agreement so we can have access directly to these products and an elevated level of control over our client’s investments.”
Takekai International, according to the new agreement, will provide its worldwide family of clients with access to the Top Hedge Fund’s investable index family, more exactly to 30 underlying investable mutual fund strategies and sub-strategies. Part of the long-term provisions in the newly signed partnership contract is the possibility of further collaboration expansion between the two financial entities that will allow Takekai International to offer tracking funds for thematic indexes.
The partnership is currently dependent on existing technological infrastructure that will be adjusted to incorporate new tools of tracking and trading for the firm’s expert traders, however, once the 3-year return goal is met, the two new partners will join forces to create a new mutual trading platform designed to host ETFs developed by both entities.
About Takekai International
Takekai International offers comprehensive investment management capabilities that span all segments of the global capital markets. The firm’s investment solutions, tailored to the unique return and risk objectives of institutional clients in more than 40 countries, draw on a robust body of proprietary research and a collaborative culture that encourages independent thought and healthy debate. Customers are the reason the firm exists and are at the heart of everything Takekai International does. That is why we seek to provide superior investment results, exceptional service, and multiple layers of risk management.
Contact Pavel Hajek - +81-905-5567-185
KISSPR PR NEWS DISCLAIMER##
This news has been published for the above source. If you purchase any items using the product and services mentioned in the link, read and accept the terms at your own risk. — Content creator did not involve the KISS PR news desk in the creation or image in this content. — KISS PR, and its distribution partners are not directly or indirectly responsible for any claims made in the above statements. — Contact the vendor of the product directly. — KISS PR or its distribution partners are not responsible for news ranking or SEO of news and its rankings. Ultimately it is always a final decision of distribution partners, and how it indexes on search engines and distribution sites. — KISS PR, or its distribution partners have no control / cannot change any ranks factors. Story.KissPR.com
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
Release ID: 15242